Astrazeneca Surges 3.53% Despite 26.72% Volume Drop Ranked 143th in Trading Activity Amid HighVolume Strategy's 166.71% Return

On July 30, 2025, Astrazeneca (AZN) rose 3.53% with a trading volume of $0.78 billion, a 26.72% decline from the previous day’s volume. The stock ranked 143rd in trading activity among listed equities.

Technical analysis from LKP Securities highlighted AstraZeneca Pharma India as a buy, with a price target of Rs 9,850 and a stop-loss at Rs 9,050. The stock broke out of a consolidation phase, trading above the 50-day exponential moving average and showing a bullish RSI crossover. Analysts noted sustained momentum as long as the stock holds above Rs 9,050, with near-term upside potential toward Rs 9,850.

A strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day generated a 166.71% return from 2022 to the present, significantly outperforming the benchmark’s 29.18% return. This highlights the strategy’s strong profitability over the period, driven by liquidity and investor interest in high-volume equities.